Alembic Pharma gets USFDA nod for generic cancer drug

19 Jun 2026via Business StandardSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Alembic Pharma gets USFDA tentative approval for generic cancer drug. This clears a key regulatory hurdle for market entry in the US. The drug will compete with branded versions, potentially boosting revenue once fully approved. Tentative approval allows Alembic to launch upon patent expiry.
📊 STOCKS: APLLTB | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA

#USFDA#genericDrug#approval

Stocks mentioned

APLLTDAPLLTD

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →